Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Avemar may help in cancer treatment, but its effectiveness isn't proven yet.

Intralesional methotrexate effectively treats alopecia areata by reducing TNF-α levels, leading to hair regrowth.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

PUVA-turban therapy can help some people with severe alopecia areata regrow hair.

An elderly woman's upper lip lump, thought to be a mucocele, was actually a rare type of lymphoma usually found on legs, treated successfully with chemotherapy and radiation.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Tadalafil and Finasteride may help treat aggressive melanoma.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Oclacitinib maleate successfully treated alopecia in Andean bears.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Dupilumab significantly improved a 5-year-old girl's prurigo nodularis without side effects.

Combining mesotherapy with systemic treatments effectively improves alopecia universalis treatment.

MS treatments can cause significant hair loss, affecting mental health.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.